loader
Please Wait
Applying Filters...

Approved Marketing Authorisations (MA) containing Lucentis in Europe. Original Data : EMA Website

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Bioeq AG

02 2Novartis Pharma Schweiz AG

03 1Samsung Bioepis CH GmbH

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Ranibizumab

Brand Name : Ranivisio

Dosage Form : Inj L?s

Dosage Strength : 2.3mg/0.23ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

02

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Ranibizumab

Brand Name : Lucentis

Dosage Form : Inj L?s

Dosage Strength : 1.65mg/0.165ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Ranibizumab

Brand Name : Lucentis

Dosage Form : Inj L?s

Dosage Strength : 2.3mg/0.23ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

04

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Ranibizumab

Brand Name : Byooviz

Dosage Form : Inj Sol

Dosage Strength : 2.3mg/0.23ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank